Royal Bank of Canada’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.81M | Buy |
|
|||||
|
2025
Q2 | $1.51M | Sell |
|
|||||
|
2025
Q1 | $1.75M | Sell |
|
|||||
|
2024
Q4 | $2.74M | Buy |
|
|||||
|
2024
Q3 | $2.72M | Buy |
|
|||||
|
2024
Q2 | $1.45M | Sell |
|
|||||
|
2024
Q1 | $1.92M | Sell |
|
|||||
|
2023
Q4 | $1.57M | Buy |
|
|||||
|
2023
Q3 | $967K | Buy |
|
|||||
|
2023
Q2 | $875K | Buy |
|
|||||
|
2023
Q1 | $753K | Buy |
|
|||||
|
2022
Q4 | $500K | Buy |
|
|||||
|
2022
Q3 | $299K | Buy |
|
|||||
|
2022
Q2 | $270K | Buy |
|
|||||
|
2022
Q1 | $299K | Buy |
|
|||||
|
2021
Q4 | $121K | Buy |
|
|||||
|
2021
Q3 | $72K | Buy |
|
|||||
|
2021
Q2 | $74K | Buy |
|
|||||
|
2021
Q1 | $17K | Sell |
|
|||||
|
2020
Q4 | $27K | Sell |
|
|||||
|
2020
Q3 | $48K | Sell |
|
|||||
|
2020
Q2 | $145K | Sell |
|
|||||
|
2020
Q1 | $213K | Sell |
|
|||||
|
2019
Q4 | $462K | Buy |
|
|||||
|
2019
Q3 | $246K | Buy |
|
|||||
|
2019
Q2 | $227K | Buy |
|
|||||
|
2019
Q1 | $196K | Sell |
|
|||||
|
2018
Q4 | $373K | Sell |
|
|||||
|
2018
Q3 | $393K | Buy |
|
|||||
|
2018
Q2 | $403K | Sell |
|
|||||
|
2018
Q1 | $721K | Buy |
|
|||||
|
2017
Q4 | $476K | Sell |
|
|||||
|
2017
Q3 | $298K | Sell |
|
|||||
|
2017
Q2 | $365K | Buy |
|
|||||
|
2017
Q1 | $261K | Buy |
|
|||||
|
2016
Q4 | $312K | Buy |
|
|||||
|
2016
Q3 | $296K | Buy |
|
|||||
|
2016
Q2 | $137K | Buy |
|
|||||
|
2016
Q1 | $205K | Buy |
|
|||||
|
2015
Q4 | $35K | Buy |
|
|||||
|
2015
Q3 | $7K | Sell |
|
|||||
|
2015
Q2 | $8K | Buy |
|